Report Reserve Announces Release of Non-Alcoholic Steatohepatitis - Pipeline Review, Q1 2011 Report

FOR IMMEDIATE RELEASE
Hyderabad, Andhra Pradesh, India, Republic of (Free-Press-Release.com) April 5, 2011 -- Report Reserve, a premium market research report store announces release of new report. For more details please visit http://www.reportreserve.com/reportdet.php?company=Global Markets Direct&report=Non-Alcoholic-Steatohepatitis---Pipeline-Review,-Q1-2011&reportid=24432
Non-Alcoholic Steatohepatitis - Pipeline Review, Q1 2011

Summary

Global Markets Direct’s, 'Non-Alcoholic Steatohepatitis - Pipeline Review, Q1 2011', provides an overview of the Non-Alcoholic Steatohepatitis therapeutic pipeline. This report provides information on the therapeutic development for Non-Alcoholic Steatohepatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Non-Alcoholic Steatohepatitis. 'Non-Alcoholic Steatohepatitis - Pipeline Review, Q1 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Non-Alcoholic Steatohepatitis.
- A review of the Non-Alcoholic Steatohepatitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Non-Alcoholic Steatohepatitis pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Non-Alcoholic Steatohepatitis.

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Non-Alcoholic Steatohepatitis pipeline depth and focus of Non-Alcoholic Steatohepatitis therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

business research     company reports     country reports     investment analysis     market research     profiles     research reports